Alnylam Pharmaceuticals, Inc.

ALNYNASDAQHealthcare● Active

$288.90

$-14.16(-4.67%)

Market Cap$38.6B

P/E Ratio—

52W High$495.55

52W Low$283.1

Avg Volume1.1M

Open$303.05

Beta0.27

Overview

Alnylam Pharmaceuticals, Inc.（ALNY）内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。

SEC EDGAR · FMP · ALNY · 截至 2026年6月8日

活动摘要

买入笔数

P-Purchase only

卖出笔数

418

近12个月

买卖比

0.00

Buy/Sell (by trades)

整体情绪

偏空

↑ Buy 0%仅显示有效交易 · 排除RSU归属100% Sell ↓

Alnylam Pharmaceuticals, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月8日

ALNY 季度内部人买卖趋势

ALNY 内幕交易卖出 · ALNY 内幕交易买入 · 季度活动

买入总量（含股权归属）卖出总量

300K150K0

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度

As of Jun 8, 2026

活跃内部人

近12个月交易最活跃 · ALNY CEO内幕交易

显示全部内部人 · 点击卡片过滤下方交易表

▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API

近期内幕交易记录

ALNY 高管卖出股份 · ALNY 董事内幕交易 · SEC Form 4申报

显示最近 85 条 · 普通股 · 仅Form 4

横向滑动查看全部列

日期	内部人	类型	股数	均价	总金额	交易后持股	申报
Jun 1, 2026	PYOTT DAVID E I Director	Option	3,830	—	—	5,412	Form 4
Jun 1, 2026	PYOTT DAVID E I Director	Sale	921	$297.71	$274K	4,491	Form 4
Jun 1, 2026	PYOTT DAVID E I Director	Sale	1,175	$298.91	$351K	3,316	Form 4
Jun 1, 2026	PYOTT DAVID E I Director	Sale	1,222	$299.87	$366K	2,094	Form 4
Jun 1, 2026	PYOTT DAVID E I Director	Sale	495	$300.72	$149K	1,599	Form 4
Jun 1, 2026	PYOTT DAVID E I Director	Sale	17	$302.65	$5K	1,582	Form 4
May 20, 2026	Sigal Charles Elliott Director	Award	671	—	—	1,446	Form 4
May 20, 2026	SCHULMAN AMY W Director	Award	838	—	—	24,049	Form 4
May 20, 2026	Reitan Colleen F Director	Award	671	—	—	1,446	Form 4
May 20, 2026	PYOTT DAVID E I Director	Award	671	—	—	1,582	Form 4
May 20, 2026	KELLOGG PETER N Director	Award	671	—	—	1,446	Form 4
May 20, 2026	HAMBURG MARGARET A Director	Award	671	—	—	1,582	Form 4
May 20, 2026	BRANDICOURT OLIVIER Director	Award	671	—	—	1,446	Form 4
May 20, 2026	Ausiello Dennis A Director	Award	671	—	—	1,582	Form 4
May 20, 2026	Arbuckle Stuart A Director	Award	671	—	—	671	Form 4
May 13, 2026	SCHULMAN AMY W Director	Option	11,250	$70.20	$790K	23,211	Form 4
Apr 2, 2026	McLaughlin Melissa Chief Human Resources Officer	Sale	265	$316.61	$84K	13,088	Form 4
Apr 2, 2026	McLaughlin Melissa Chief Human Resources Officer	Sale	359	$317.44	$114K	12,729	Form 4
Apr 2, 2026	McLaughlin Melissa Chief Human Resources Officer	Sale	209	$318.47	$67K	12,520	Form 4
Apr 2, 2026	McLaughlin Melissa Chief Human Resources Officer	Sale	86	$319.69	$27K	12,434	Form 4
Apr 2, 2026	McLaughlin Melissa Chief Human Resources Officer	Sale	147	$320.62	$47K	12,287	Form 4
Apr 2, 2026	McLaughlin Melissa Chief Human Resources Officer	Sale	224	$321.64	$72K	12,063	Form 4
Apr 2, 2026	McLaughlin Melissa Chief Human Resources Officer	Sale	245	$322.86	$79K	11,818	Form 4
Apr 2, 2026	McLaughlin Melissa Chief Human Resources Officer	Sale	81	$323.64	$26K	11,737	Form 4
Apr 2, 2026	McLaughlin Melissa Chief Human Resources Officer	Sale	8	$325.49	$3K	11,729	Form 4

PYOTT DAVID E I

Director

Option

日期

Jun 1

股数

3,830

均价

—

总金额

—

View Form 4 on SEC.gov

PYOTT DAVID E I

Director

Sale

日期

Jun 1

股数

921

均价

$297.71

总金额

$274K

View Form 4 on SEC.gov

PYOTT DAVID E I

Director

Sale

日期

Jun 1

股数

1,175

均价

$298.91

总金额

$351K

View Form 4 on SEC.gov

PYOTT DAVID E I

Director

Sale

日期

Jun 1

股数

1,222

均价

$299.87

总金额

$366K

View Form 4 on SEC.gov

PYOTT DAVID E I

Director

Sale

日期

Jun 1

股数

495

均价

$300.72

总金额

$149K

View Form 4 on SEC.gov

PYOTT DAVID E I

Director

Sale

日期

Jun 1

股数

均价

$302.65

总金额

$5K

View Form 4 on SEC.gov

Sigal Charles Elliott

Director

Award

日期

May 20

股数

671

均价

—

总金额

—

View Form 4 on SEC.gov

SCHULMAN AMY W

Director

Award

日期

May 20

股数

838

均价

—

总金额

—

View Form 4 on SEC.gov

Reitan Colleen F

Director

Award

日期

May 20

股数

671

均价

—

总金额

—

View Form 4 on SEC.gov

PYOTT DAVID E I

Director

Award

日期

May 20

股数

671

均价

—

总金额

—

View Form 4 on SEC.gov

KELLOGG PETER N

Director

Award

日期

May 20

股数

671

均价

—

总金额

—

View Form 4 on SEC.gov

HAMBURG MARGARET A

Director

Award

日期

May 20

股数

671

均价

—

总金额

—

View Form 4 on SEC.gov

BRANDICOURT OLIVIER

Director

Award

日期

May 20

股数

671

均价

—

总金额

—

View Form 4 on SEC.gov

Ausiello Dennis A

Director

Award

日期

May 20

股数

671

均价

—

总金额

—

View Form 4 on SEC.gov

Arbuckle Stuart A

Director

Award

日期

May 20

股数

671

均价

—

总金额

—

View Form 4 on SEC.gov

SCHULMAN AMY W

Director

Option

日期

May 13

股数

11,250

均价

$70.20

总金额

$790K

View Form 4 on SEC.gov

McLaughlin Melissa

Chief Human Resources Officer

Sale

日期

Apr 2

股数

265

均价

$316.61

总金额

$84K

View Form 4 on SEC.gov

McLaughlin Melissa

Chief Human Resources Officer

Sale

日期

Apr 2

股数

359

均价

$317.44

总金额

$114K

View Form 4 on SEC.gov

McLaughlin Melissa

Chief Human Resources Officer

Sale

日期

Apr 2

股数

209

均价

$318.47

总金额

$67K

View Form 4 on SEC.gov

McLaughlin Melissa

Chief Human Resources Officer

Sale

日期

Apr 2

股数

均价

$319.69

总金额

$27K

View Form 4 on SEC.gov

McLaughlin Melissa

Chief Human Resources Officer

Sale

日期

Apr 2

股数

147

均价

$320.62

总金额

$47K

View Form 4 on SEC.gov

McLaughlin Melissa

Chief Human Resources Officer

Sale

日期

Apr 2

股数

224

均价

$321.64

总金额

$72K

View Form 4 on SEC.gov

McLaughlin Melissa

Chief Human Resources Officer

Sale

日期

Apr 2

股数

245

均价

$322.86

总金额

$79K

View Form 4 on SEC.gov

McLaughlin Melissa

Chief Human Resources Officer

Sale

日期

Apr 2

股数

均价

$323.64

总金额

$26K

View Form 4 on SEC.gov

McLaughlin Melissa

Chief Human Resources Officer

Sale

日期

Apr 2

股数

均价

$325.49

总金额

$3K

View Form 4 on SEC.gov

⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股

1 / 4

▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 ALNY 内幕交易

ALNY 内幕交易

Alnylam Pharmaceuticals, Inc.（ALNY）内幕交易数据来源于公司内部人（包括Poulton Jeffrey V. (EVP, Chief Financial Officer), McLaughlin Melissa (Chief Human Resources Officer), Garg Pushkal (EVP Chief R&D)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。ALNY内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。

如需查看Alnylam Pharmaceuticals, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →

买卖信号逻辑

acquisitionOrDisposition字段：

A = 买入 · D = 卖出（处置）

RSU归属（M-Exempt）不计入情绪判断

Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件

10b5-1预设交易计划，允许内部人按计划自动卖出

Open Mkt公开市场直接买卖（不含股权奖励和期权行权）

机构持仓 SEC 申报财务报表价格历史预测与评级财报

常见问题

ALNY 内幕交易 · 5个问题

Alnylam Pharmaceuticals, Inc.（ALNY）的内部人包括高管和董事，如Poulton Jeffrey V. (EVP, Chief Financial Officer), McLaughlin Melissa (Chief Human Resources Officer), Garg Pushkal (EVP Chief R&D)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

ALNY 董事内幕交易ALNY 内部人名单Alnylam Pharmaceuticals, Inc. 高管内幕活动

▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026